Opportunities and perspectives for developing orexin receptor antagonists

Por Steiner, Michel A., Winrow, Christopher J.
Publicado em 2014

The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome

Por Steiner, Michel A., Sciarretta, Carla, Pasquali, Anne, Jenck, Francois
Publicado em 2013

Differential Effects of the Dual Orexin Receptor Antagonist Almorexant and the GABA(A)-α1 Receptor Modulator Zolpidem, Alone or Combined with Ethanol, on Motor Performance in the R...

Por Steiner, Michel A, Lecourt, Hugues, Strasser, Daniel S, Brisbare-Roch, Catherine, Jenck, François
Publicado em 2011

Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice

Por Steiner, Michel A, Marsicano, Giovanni, Nestler, Eric J, Holsboer, Florian, Lutz, Beat, Wotjak, Carsten T
Publicado em 2007

ΔFosB in brain reward circuits mediates resilience to stress and antidepressant responses

Por Vialou, Vincent, Robison, Alfred J., LaPlant, Quincey C., Covington, Herb E., Dietz, David M., Ohnishi, Yoshinori N., Mouzon, Ezekiell, Rush, Augustus J., Watts, Emily L., Wallace, Deanna L., Iniguez, Sergio D., Ohnishi, Yoko H., Steiner, Michel A., Warren, Brandon, Krishnan, Vaishnav, Neve, Rachael L., Ghose, Subroto, Berton, Olivier, Tamminga, Carol A., Nestler, Eric J.
Publicado em 2010